Position history for Fundsmith LLP's holdings in CATALYST PHARMACEUTICALS INC
Fundsmith LLP holds 3.4M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $78.5M as of 2025-Q4. CPRX represents 0.5% of Fundsmith LLP's portfolio.
Current Value
$78.5M
Current Shares
3.4M
Total Value Change
+$26.3M
Total Shares Change
+1.2M
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 3.4M |
0.0% |
| $78.5M |
| 0.5% |
| $23.29 |
0 |
| 2025-Q3 | Increased | 3.4M | +24.2% | $66.3M | 0.3% | $19.55 | 44 |
| 2025-Q2 | Increased | 2.7M | +25.9% | $58.8M | 0.3% | $21.78 | 44 |
| 2025-Q1 | New | 2.2M | - | $52.2M | 0.2% | $24.69 | 50 |